Find support groups, events and resources near you

Active Surveillance for Intermediate-risk Prostate Cancer Challenged

New study findings suggest there is no “favorable” subset of patients with intermediate-risk prostate cancer (PCa) likely to benefit from active surveillance.

Read more.


Source: Renal and Urology News

Share